Explore the words cloud of the EVIDENT project. It provides you a very rough idea of what is the project "EVIDENT" about.
The following table provides information about the project.
Coordinator |
BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
Organization address contact info |
Coordinator Country | Germany [DE] |
Project website | http://www.evident-project.eu |
Total cost | 1˙759˙325 € |
EC max contribution | 1˙759˙325 € (100%) |
Programme |
1. H2020-EU.3.1. (SOCIETAL CHALLENGES - Health, demographic change and well-being) |
Code Call | H2020-Adhoc-2014-20 |
Funding Scheme | RIA |
Starting year | 2014 |
Duration (year-month-day) | from 2014-11-01 to 2016-10-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN | DE (HAMBURG) | coordinator | 481˙660.00 |
2 | Department of Health | UK (Leeds) | participant | 406˙943.00 |
3 | ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO | IT (ROMA) | participant | 226˙465.00 |
4 | EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH | DE (ST INGBERT) | participant | 163˙375.00 |
5 | BUNDESMINISTERIUM DER VERTEIDIGUNG | DE (BONN) | participant | 73˙625.00 |
6 | PHILIPPS UNIVERSITAET MARBURG | DE (MARBURG) | participant | 73˙625.00 |
7 | ROBERT KOCH-INSTITUT | DE (Berlin) | participant | 73˙437.00 |
8 | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE | FR (PARIS) | participant | 73˙193.00 |
9 | ORSZAGOS EPIDEMIOLOGIAI KOZPONT | HU (BUDAPEST) | participant | 72˙500.00 |
10 | UNIVERZA V LJUBLJANI | SI (LJUBLJANA) | participant | 72˙000.00 |
11 | ARTSEN ZONDER GRENZEN (MEDECINS SANS FRONTIERES NEDERLAND) VERENIGING | NL (Amsterdam) | participant | 42˙500.00 |
The Ebola virus disease (EVD) epidemic in West Africa is not under control. This proposal has immediate, mid-term and long-term objectives to combat the current and future EVD epidemics. Objectives with immediate impact are: (i) Providing key information needed to implement efficient convalescent plasma treatment and a toolkit to determine the suitability of plasma for treatment; (ii) Providing key information needed to estimate the efficacy of experimental vaccines, including correlates of protection at T cell level; (iii) Improving supportive treatment of patients and reducing hospital case fatality rate by providing information on biomarkers and relevant co-infections; (iv) Monitoring development of mutations in Ebola virus (EBOV) genomes during the epidemic and enhancing our preparedness to determine the relevance of these changes in experimental systems; and (v) Protecting health care workers and communities by providing information on virus shedding in body fluids and estimation of infectiousness in various stages of EVD. Objectives with mid to long-term impact are: (i) Provide information on pathophysiological changes and immunological determinants to infer new immunotherapeutic strategies for treatment of EVD; and (ii) Strengthening cooperation of biosafety level 4 (BSL-4) facilities and building a pan-European research area in the field of highly pathogenic viruses as envisaged in the ‘European Research Infrastructure on Highly Pathogenic Agents’ project. The concept of EVIDENT is to scientifically exploit specimens collected from EVD patients during outbreak response and field research. We will use state-of-the-art methodologies within the EU BSL-4 facilities to gather new and outbreak-relevant knowledge on B and T cell immunology, biomarkers, virus evolution, virulence determinants, and transmission of EBOV. The consortium contributes to the outbreak response since March 2014 and is competent to implement a project in the outbreak area.
External project website | Websites, patent fillings, videos etc. | 2019-07-25 12:47:38 |
Take a look to the deliverables list in detail: detailed list of EVIDENT deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2015 |
Vincent Madelain, Lisa Oestereich, Frederik Graw, Thi Huyen Tram Nguyen, Xavier de Lamballerie, France Mentré, Stephan Günther, Jeremie Guedj Ebola virus dynamics in mice treated with favipiravir published pages: 70-77, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2015.08.015 |
Antiviral Research 123 | 2019-07-25 |
2016 |
Erik Dietzel, Gordian Schudt, Verena Krähling, Mikhail Matrosovich, Stephan Becker Functional characterization of adaptive mutations during the West African Ebola virus outbreak published pages: JVI.01913-16, ISSN: 0022-538X, DOI: 10.1128/JVI.01913-16 |
Journal of Virology | 2019-07-25 |
2016 |
Séverine Caluwaerts, Tessy Fautsch, Daphne Lagrou, Michel Moreau, Alseny Modet Camara, Stephan Günther, Antonino Di Caro, Benny Borremans, Fara Raymond Koundouno, Joseph Akoi Bore, Christopher H. Logue, Martin Richter, Roman Wölfel, Eeva Kuisma, Andreas Kurth, Stephen Thomas, Gillian Burkhardt, Elin Erland, Fanshen Lionetto, Patricia Lledo Weber, Olimpia de la Rosa, Hassan Macpherson, Michel Va Dilemmas in Managing Pregnant Women With Ebola: 2 Case Reports: Table 1. published pages: 903-905, ISSN: 1058-4838, DOI: 10.1093/cid/civ1024 |
Clinical Infectious Diseases 62/7 | 2019-07-25 |
2016 |
Joshua Quick, Nicholas J. Loman, Sophie Duraffour, Jared T. Simpson, Ettore Severi, Lauren Cowley, Joseph Akoi Bore, Raymond Koundouno, Gytis Dudas, Amy Mikhail, Nobila Ouédraogo, Babak Afrough, Amadou Bah, Jonathan H. J. Baum, Beate Becker-Ziaja, Jan Peter Boettcher, Mar Cabeza-Cabrerizo, Ãlvaro Camino-Sánchez, Lisa L. Carter, Juliane Doerrbecker, Theresa Enkirch, Isabel GarcÃa- Dorival, Nico Real-time, portable genome sequencing for Ebola surveillance published pages: 228-232, ISSN: 0028-0836, DOI: 10.1038/nature16996 |
Nature 530/7589 | 2019-07-25 |
2016 |
Toni Rieger, Romy Kerber, Hussein El Halas, Elisa Pallasch, Sophie Duraffour, Stephan Günther, Stephan Ölschläger Evaluation of RealStar Reverse Transcription–Polymerase Chain Reaction Kits for Filovirus Detection in the Laboratory and Field published pages: S243-S249, ISSN: 0022-1899, DOI: 10.1093/infdis/jiw246 |
Journal of Infectious Diseases 214/suppl 3 | 2019-07-25 |
2016 |
Paula Ruibal, Lisa Oestereich, Anja Lüdtke, Beate Becker-Ziaja, David M. Wozniak, Romy Kerber, Miša Korva, Mar Cabeza-Cabrerizo, Joseph A. Bore, Fara Raymond Koundouno, Sophie Duraffour, Romy Weller, Anja Thorenz, Eleonora Cimini, Domenico Viola, Chiara Agrati, Johanna Repits, Babak Afrough, Lauren A. Cowley, Didier Ngabo, Julia Hinzmann, Marc Mertens, Inês Vitoriano, Christopher H. Logue, Jan Unique human immune signature of Ebola virus disease in Guinea published pages: 100-104, ISSN: 0028-0836, DOI: 10.1038/nature17949 |
Nature 533/7601 | 2019-07-25 |
2016 |
Boubacar Diallo, Daouda Sissoko, Nicholas J. Loman, Hadja Aïssatou Bah, Hawa Bah, Mary Claire Worrell, lya Saidou Conde, Ramata Sacko, Samuel Mesfin, Angelo Loua, Jacques Katomba Kalonda, Ngozi A. Erondu, Benjamin A. Dahl, Susann Handrick, Ian Goodfellow, Luke W. Meredith, Matthew Cotten, Umaru Jah, Raoul Emeric Guetiya Wadoum, Pierre Rollin, N\'Faly Magassouba, Denis Malvy, Xavier Anglaret, Miles Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days published pages: 1353-1356, ISSN: 1058-4838, DOI: 10.1093/cid/ciw601 |
Clinical Infectious Diseases 63/10 | 2019-07-25 |
2016 |
Verena Krähling, Dirk Becker, Cornelius Rohde, Markus Eickmann, Yonca Eroğlu, Astrid Herwig, Romy Kerber, Katharina Kowalski, Júlia Vergara-Alert, Stephan Becker Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus published pages: 173-183, ISSN: 0300-8584, DOI: 10.1007/s00430-015-0438-6 |
Medical Microbiology and Immunology 205/2 | 2019-07-25 |
2016 |
Daouda Sissoko, Cedric Laouenan, Elin Folkesson, Abdoul-Bing M’Lebing, Abdoul-Habib Beavogui, Sylvain Baize, Alseny-Modet Camara, Piet Maes, Susan Shepherd, Christine Danel, Sara Carazo, Mamoudou N. Conde, Jean-Luc Gala, Géraldine Colin, Hélène Savini, Joseph Akoi Bore, Frederic Le Marcis, Fara Raymond Koundouno, Frédéric Petitjean, Marie-Claire Lamah, Sandra Diederich, Alexis Tounkara, Gee Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea published pages: e1001967, ISSN: 1549-1676, DOI: 10.1371/journal.pmed.1001967 |
PLOS Medicine 13/3 | 2019-07-25 |
2016 |
C Agrati, C Castilletti, R Casetti, A Sacchi, L Falasca, F Turchi, N Tumino, V Bordoni, E Cimini, D Viola, E Lalle, L Bordi, S Lanini, F Martini, E Nicastri, N Petrosillo, V Puro, M Piacentini, A Di Caro, G P Kobinger, A Zumla, G Ippolito, M R Capobianchi Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection published pages: e2164, ISSN: 2041-4889, DOI: 10.1038/cddis.2016.55 |
Cell Death and Disease 7/3 | 2019-07-25 |
2016 |
Romy Kerber, Ralf Krumkamp, Boubacar Diallo, Anna Jaeger, Martin Rudolf, Simone Lanini, Joseph Akoi Bore, Fara Raymond Koundouno, Beate Becker-Ziaja, Erna Fleischmann, Kilian Stoecker, Silvia Meschi, Stéphane Mély, Edmund N. C. Newman, Fabrizio Carletti, Jasmine Portmann, Misa Korva, Svenja Wolff, Peter Molkenthin, Zoltan Kis, Anne Kelterbaum, Anne Bocquin, Thomas Strecker, Alexandra Fizet, Conc Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015 published pages: S250-S257, ISSN: 0022-1899, DOI: 10.1093/infdis/jiw269 |
Journal of Infectious Diseases 214/suppl 3 | 2019-07-25 |
2016 |
Anja Lüdtke, Paula Ruibal, Beate Becker-Ziaja, Monika Rottstegge, David M. Wozniak, Mar Cabeza-Cabrerizo, Anja Thorenz, Romy Weller, Romy Kerber, Juliana Idoyaga, N\'Faly Magassouba, Martin Gabriel, Stephan Günther, Lisa Oestereich, César Muñoz-Fontela Ebola Virus Disease Is Characterized by Poor Activation and Reduced Levels of Circulating CD16 + Monocytes published pages: S275-S280, ISSN: 0022-1899, DOI: 10.1093/infdis/jiw260 |
Journal of Infectious Diseases 214/suppl 3 | 2019-07-25 |
2015 |
Thomas Strecker, Bernadett Palyi, Heinz Ellerbrok, Sylvie Jonckheere, Hilde de Clerck, Joseph Akoi Bore, Martin Gabriel, Kilian Stoecker, Markus Eickmann, Michel van Herp, Pierre Formenty, Antonino Di Caro, Stephan Becker Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency published pages: 669-675, ISSN: 1058-4838, DOI: 10.1093/cid/civ397 |
Clinical Infectious Diseases 61/5 | 2019-07-25 |
2015 |
Miles W. Carroll, David A. Matthews, Julian A. Hiscox, Michael J. Elmore, Georgios Pollakis, Andrew Rambaut, Roger Hewson, Isabel GarcÃa-Dorival, Joseph Akoi Bore, Raymond Koundouno, Saïd Abdellati, Babak Afrough, John Aiyepada, Patience Akhilomen, Danny Asogun, Barry Atkinson, Marlis Badusche, Amadou Bah, Simon Bate, Jan Baumann, Dirk Becker, Beate Becker-Ziaja, Anne Bocquin, Benny Borremans, A Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa published pages: 97-101, ISSN: 0028-0836, DOI: 10.1038/nature14594 |
Nature 524/7563 | 2019-07-25 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EVIDENT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EVIDENT" are provided by the European Opendata Portal: CORDIS opendata.